AMANDA DIBENEDETTO: Open Payments
NPI 1972810976 · GEORGETOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 85 payments from 17 companies in 2025. Trend: 2023 $864 · 2024 $1,096 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $302 |
| ABBVIE INC. | 23 | $277 |
| Amgen Inc. | 16 | $195 |
| E.R. Squibb & Sons, L.L.C. | 5 | $80 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Galderma Laboratories, L.P. | 3 | $63 |
| UCB, Inc. | 3 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $36 |
| Incyte Corporation | 2 | $33 |
Products named: SKYRIZI, OTEZLA, COSENTYX, Sotyktu, DUPIXENT, Winlevi, Rhapsido, AKLIEF.
Industry payments across TX — which companies pay providers there.
